Lanosterol Synthase (2,3-Oxidosqualene-Lanosterol Cyclase) (LSS) Peptide
-
- Target See all LSS products
- LSS (Lanosterol Synthase (2,3-Oxidosqualene-Lanosterol Cyclase) (LSS))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- KCPHVTEHIP RERLCDAVAV LLNMRNPDGG FATYETKRGG HLLELLNPSE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LSS antibody,
Alternative Names: LSS control peptide, LSS antibody Blocking Peptide, Anti-LSS Blocking Peptide, Lanosterol Synthase Blocking Peptide, 2,3-Oxidosqualene-Lanosterol Cyclase Blocking Peptide, OSC Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LSS (Lanosterol Synthase (2,3-Oxidosqualene-Lanosterol Cyclase) (LSS))
- Background
- LSS catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. It is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Two transcript variants encoding the same protein have been found for this gene.
- Molecular Weight
- 83 kDa
-